Elderly care home residents and the immunosuppressed, such as cancer patients, will receive jabs first as UK scientists continue to investigate the new variant.
Elderly care home residents and the immunosuppressed, such as cancer patients, will receive jabs first as UK scientists continue to investigate the new variant.